Edward Parent Appointed Director of Quality Assurance at TissueGen
26. September 2017 10:30 ET
|
TissueGen, Inc
DALLAS, Sept. 26, 2017 (GLOBE NEWSWIRE) -- TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced that Edward Parent has...
TissueGen Wins 2017 Future Textiles Award for Most Innovative Small Company
18. Mai 2017 09:48 ET
|
TissueGen, Inc
DALLAS, May 18, 2017 (GLOBE NEWSWIRE) -- TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue...
TissueGen Featured in Nature.com Webcast on Innovations in Drug Delivery Technology
22. März 2017 10:00 ET
|
TissueGen, Inc.
DALLAS, TX--(Marketwired - Mar 22, 2017) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and...
Dr. Lisa A. Fortier Joins TissueGen's Scientific Advisory Board
27. Februar 2017 10:00 ET
|
TissueGen Inc
DALLAS, TX--(Marketwired - Feb 27, 2017) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced that Lisa A....
TissueGen Announces ISO13485:2003 Certification and Record Growth Driven by ELUTE Fiber
28. März 2016 10:00 ET
|
TissueGen Inc.
DALLAS, TX--(Marketwired - Mar 28, 2016) - TissueGen® Inc., developer of ELUTE® fiber, controlled, sustained drug delivery from bioresorbable fiber, has been awarded ISO13485:2003...
TissueGen's New ISO Class 7 Facility Supports FDA cGMP Drug Product Manufacturing
15. Dezember 2015 12:00 ET
|
TissueGen(R) Inc.
DALLAS, TX--(Marketwired - Dec 15, 2015) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced the...
TissueGen's ELUTE Fiber Wins 2015 R&D 100 Award
01. Dezember 2015 10:00 ET
|
TissueGen Inc.
DALLAS, TX--(Marketwired - Dec 1, 2015) - TissueGen® Inc., developer of ELUTE® fiber, groundbreaking biodegradable fiber for delivery of the broadest range of therapeutic drugs, has been...
TissueGen Appoints Dr. Jennifer Seifert as Senior Scientist to Lead Spinal Cord Injury Repair Program
23. Juni 2015 10:00 ET
|
TissueGen(R) Inc.
DALLAS, TX--(Marketwired - Jun 23, 2015) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced that...
TissueGen Expands Core Team and Advances Spinal Cord Injury Repair and Regenerative Medicine Applications in 2014
20. Januar 2015 10:00 ET
|
TissueGen Inc
DALLAS, TX--(Marketwired - Jan 20, 2015) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, closed out 2014 with the...
Regenerative Neurobiology Experts' Session at Neuroscience 2014 Demonstrates TissueGen's Approach to Nerve Repair
13. November 2014 10:00 ET
|
TissueGen Inc.
DALLAS, TX--(Marketwired - Nov 13, 2014) - TissueGen® Inc., developer of a groundbreaking biodegradable fiber format for drug delivery, today announced that they will be attending the...